| Deafness alters auditory nerve fibre responses to cochlear implant stimulation DJ Sly, LF Heffer, MW White, RK Shepherd, MGJ Birch, RL Minter, ... European Journal of Neuroscience 26 (2), 510-522, 2007 | 71 | 2007 |
| Safety and efficacy of induction and maintenance avelumab plus R-CHOP in patients with diffuse large B-cell lymphoma (DLBCL): analysis of the Phase II Avr-CHOP Study EA Hawkes, G Chong, C Smith, ST Lee, L Churilov, J McKendrick, ... Blood 136, 43-44, 2020 | 14 | 2020 |
| Characterisation of immune checkpoints in Richter syndrome identifies LAG3 as a potential therapeutic target C Gould, J Lickiss, Y Kankanige, S Yerneni, S Lade, MK Gandhi, C Chin, ... British Journal of Haematology 195 (1), 113-118, 2021 | 11 | 2021 |
| A multicenter retrospective comparison of induction chemoimmunotherapy regimens on outcomes in transplant‐eligible patients with previously untreated mantle cell lymphoma ZY Ng, M Bishton, D Ritchie, R Campbell, M Gilbertson, K Hill, ... Hematological oncology 37 (3), 253-260, 2019 | 7 | 2019 |
| Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP study K Manos, G Chong, C Keane, ST Lee, C Smith, L Churilov, J McKendrick, ... Leukemia 37 (5), 1092-1102, 2023 | 5 | 2023 |
| Management and outcomes of diffuse large B‐cell lymphoma post‐transplant lymphoproliferative disorder in the era of PET and rituximab: a multicenter study from the Australasian … S Boyle, JWD Tobin, J Perram, N Hamad, V Gullapalli, A Barraclough, ... HemaSphere 5 (11), e648, 2021 | 5 | 2021 |
| Blastic plasmacytoid dendritic cell neoplasm (BPDCN) in leukaemic phase without skin lesions: a diagnostic and management challenge N Murphy, D Owens, E Hinds, N Nelson Pathology 51 (4), 439-441, 2019 | 4 | 2019 |
| Functional genomics for curation of variants in telomere biology disorder associated genes: A systematic review N Nelson, S Feurstein, A Niaz, J Truong, JK Holien, S Lucas, K Fairfax, ... Genetics in Medicine 25 (3), 100354, 2023 | 2 | 2023 |
| Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): VEXAS SYNDROME IDENTIFIED ON SOMATIC NGS PANEL IN A FRACTION OF PATIENTS OF … S Sadawarte, N Nelson, R Vanhaeften, J Marthick, A Sharma, A Bapat, ... Leukemia Research 128, 107154, 2023 | | 2023 |
| Diagnostically challenging immunophenotypic shift in mantle cell lymphoma following ibrutinib venetoclax therapy. WRM Leitinger EJ, Nelson NE, A MA, B A., L S, R AW, and Juneja S Pathology 53 (7), 926-929, 2021 | | 2021 |
| Management and Outcomes of Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder in the PET/CT Era: A Multicentre Study from the Australasian Lymphoma Alliance S Boyle, JWD Tobin, J Perram, N Hamad, A Barraclough, L Singaraveloo, ... Blood 136, 36-38, 2020 | | 2020 |
| Characterization of the “Immune Evasion” Phenotype of Richter Syndrome and the Implications for Immune-Checkpoint Inhibitor Therapy C Gould, J Lickiss, Y Kankanige, S Yerneni, J Markham, CK Yannakou, ... Blood 134, 4290, 2019 | | 2019 |
| CD4 negative leukaemoid blastic plasmacytoid dendritic cell neoplasm–A case report N Nelson, D Owens, E Hinds, N Murphy Pathology 50, S106-S107, 2018 | | 2018 |
| An International Multicenter Retrospective Comparison of Induction Chemoimmunotherapy Regimens on Outcomes in Patients with Transplant-Eligible Mantle Cell Lymphoma ZY Ng, M Bishton, D Ritchie, R Campbell, MP Gilbertson, K Hill, ... Blood 130, 4052, 2017 | | 2017 |
